CTLA4 and hepatocellular carcinoma: We found that compared with the HCC group and the SD-HCC add CTLA-4 inhibitor groups, the SD-HCC group had a stronger migration ability (Figures 4A,B) and stronger invasion ability (Figures 4C,D).